Gilead Sciences (GILD) FCF Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,396.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-935.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
1,326.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
1,043.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
511.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,008.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
934.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-853.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,008.00 |
| Dec 31, 2025 |
203.00 |
| Sep 30, 2025 |
-426.00 |
| Jun 30, 2025 |
-702.00 |
| Mar 31, 2025 |
-682.00 |
| Dec 31, 2024 |
990.00 |
| Sep 30, 2024 |
3,208.00 |
| Jun 30, 2024 |
-1,614.00 |
| Mar 31, 2024 |
588.00 |
| Dec 31, 2023 |
-482.00 |
| Sep 30, 2023 |
-1,527.00 |
| Jun 30, 2023 |
682.00 |
| Mar 31, 2023 |
157.00 |
| Dec 31, 2022 |
-980.00 |
| Sep 30, 2022 |
-354.00 |
| Jun 30, 2022 |
-884.00 |
| Mar 31, 2022 |
-1,389.00 |
| Dec 31, 2021 |
1,871.00 |
| Sep 30, 2021 |
1,011.00 |
| Jun 30, 2021 |
-1,177.00 |
| Mar 31, 2021 |
1,527.00 |
| Dec 31, 2020 |
-1,705.00 |
| Sep 30, 2020 |
-1,178.00 |
| Jun 30, 2020 |
917.00 |
| Mar 31, 2020 |
-257.00 |
| Dec 31, 2019 |
425.00 |
| Sep 30, 2019 |
709.00 |
| Jun 30, 2019 |
1,535.00 |
| Mar 31, 2019 |
-1,507.00 |
| Dec 31, 2018 |
-639.00 |
| Sep 30, 2018 |
-284.00 |
| Jun 30, 2018 |
-2,506.00 |
| Mar 31, 2018 |
-270.00 |
| Dec 31, 2017 |
-346.00 |
| Sep 30, 2017 |
-1,654.00 |
| Jun 30, 2017 |
-1,383.00 |
| Mar 31, 2017 |
-757.00 |
| Dec 31, 2016 |
-2,014.00 |
| Sep 30, 2016 |
1,000.00 |
| Jun 30, 2016 |
-507.00 |
| Mar 31, 2016 |
-2,272.00 |
| Dec 31, 2015 |
2,716.00 |
| Sep 30, 2015 |
-1,877.00 |
| Jun 30, 2015 |
391.00 |
| Mar 31, 2015 |
4,535.00 |
| Dec 31, 2014 |
1,793.00 |
| Sep 30, 2014 |
3,897.00 |
| Jun 30, 2014 |
2,984.00 |
| Mar 31, 2014 |
308.00 |
| Dec 31, 2013 |
424.00 |
| Sep 30, 2013 |
-225.00 |
| Jun 30, 2013 |
-1,930.00 |
| Mar 31, 2013 |
618.00 |
| Dec 31, 2012 |
-2,641.00 |
| Sep 30, 2012 |
-1,128.00 |
| Jun 30, 2012 |
922.00 |
| Mar 31, 2012 |
-2,300.00 |
| Dec 31, 2011 |
817.00 |
| Sep 30, 2011 |
165.00 |
| Jun 30, 2011 |
745.00 |
| Mar 31, 2011 |
1,024.00 |
| Dec 31, 2010 |
-1,058.00 |
| Sep 30, 2010 |
-916.00 |
| Jun 30, 2010 |
-111.00 |
| Mar 31, 2010 |
41.00 |
